menu

Lessons Learned from Implementing Gene Therapy for Hemophilia

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Working Towards Implementing Gene Therapy for Hemophilia

ReachMD Healthcare Image
Restart
Resume
Read full article
Choose a format
Media formats available:
Completing the pre-test is required to view this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Related
Comments
  • Sponsored by

  • Overview

    As we continue to explore the role gene therapy may play in treating patients with hemophilia, what do we need to consider? Joining Dr. Charles Turck to share key lessons learned from implementing gene therapy in the clinical trial setting are Drs. Steven Pipe and Giancarlo Castaman.

  • Disclaimer

    Gene therapy for hemophilia B is currently under clinical investigation and is not approved by any regulatory authority for therapeutic use. 

    This non-certified educational episode is sponsored by CSL Behring. Content for this episode is produced and controlled by ReachMD. This episode is intended for healthcare professionals only.

Facebook Comments

Recommended
Details
Presenters
Related
Comments
  • Sponsored by

  • Overview

    As we continue to explore the role gene therapy may play in treating patients with hemophilia, what do we need to consider? Joining Dr. Charles Turck to share key lessons learned from implementing gene therapy in the clinical trial setting are Drs. Steven Pipe and Giancarlo Castaman.

  • Disclaimer

    Gene therapy for hemophilia B is currently under clinical investigation and is not approved by any regulatory authority for therapeutic use. 

    This non-certified educational episode is sponsored by CSL Behring. Content for this episode is produced and controlled by ReachMD. This episode is intended for healthcare professionals only.

Facebook Comments

Schedule22 May 2022
Webpack App